Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer.

ABSTRACT:

Importance

The current staging system of gastric cancer is not adequate for defining a prognosis and predicting the patients most likely to benefit from chemotherapy.

Objective

To construct a survival prediction model based on specific tumor and patient characteristics that enables individualized predictions of the net survival benefit of adjuvant chemotherapy for patients with stage II or stage III gastric cancer.

Design, setting, and participants

In this multicenter retrospective analysis, a survival prediction model was constructed using data from a training cohort of 746 patients with stage II or stage III gastric cancer who satisfied the study's inclusion criteria and underwent surgery between January 1, 2004, and December 31, 2012, at Nanfang Hospital in Guangzh

SUBMITTER: Jiang Y 

PROVIDER: S-EPMC5831463 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature